\-\ Texto\\:\\ \ \(0\)\
\-\ drop\\ in\\ the\\ patient\\'s\\ hemoglobin\\ and\\ hematocrit\\ from\\ 9\\.1\\/26\\.7\\ to\\ 5\\.9\\/17\\.4\\ within\\ a\\ 24\\ hour\\ period\\ and\\ the\\ development\\ of\\ a\\ palpable\\ left\\ sided\\ tender\\ adbominal\\ mass\\.\\ \\ just\\ prior\\ to\\ her\\ ct\\ scan\\,\\ while\\ receiving\\ heparin\\,\\ the\\ patient\\'s\\ pt\\ was\\ 18\\.3\\ \\(nml\\ 11\\-13\\.8\\)\\,\\ ptt\\ was\\ 133\\.7\\ \\(23\\.8\\-35\\.5\\)\\,\\ pt\\ ratio\\ 1\\.5\\,\\ inr\\ 2\\.0\\.\ \(0\)\
\-\ temporary\\ withdrawal\\ of\\ anticoagulation\\.\ \(0\)\
\-\ non\\ contrast\\ ct\\ of\\ the\\ abdomen\\ and\\ the\\ pelvis\\ demonstrates\\ a\\ large\\ hyperdense\\ heterogeneous\\ mass\\ at\\ the\\ left\\ lateral\\ abdominal\\ wall\\,\\ not\\ present\\ on\\ a\\ prior\\ ct\\ of\\ the\\ abdomen\\ from\\ less\\ than\\ a\\ week\\ prior\\.\ \(0\)\
\-\ abdominal\\ wall\\ hematoma\\ following\\ the\\ initiation\\ of\\ therapeutic\\ anticoagultion\\.\ \(0\)\
\-\ acute\\ hemorrhage\\/hematoma\ \(0\)\
\-\ abscess\ \(594\)\
\-\ soft\\ tissue\\ neoplasm\ \(2\)\
\-\ 56\\ year\\ old\\ female\\ patient\\ in\\ the\\ intensive\\ care\\ unit\\ found\\ to\\ have\\ a\\ sudden\\ drop\\ in\\ her\\ hemoglobin\\ and\\ hematocrit\\ following\\ the\\ recent\\ initiation\\ of\\ anticoagulation\\ therapy\\ for\\ a\\ pulmonary\\ embolus\\.\ \(1\)\
\-\ this\\ patient\\ was\\ being\\ started\\ on\\ anticoagulation\\ therapy\\ for\\ a\\ recent\\ pulmonary\\ embolism\\ with\\ intravenous\\ heparin\\.\\ \\ her\\ ptt\\ was\\ elevated\\ at\\ 133\\.7\\,\\ which\\ falls\\ beyond\\ the\\ goal\\ of\\ 70\\-90\\ \\(by\\ this\\ institution\\'s\\ laboratory\\)\\ for\\ a\\ patient\\ starting\\ anticoagulation\\.\\ \\ unfortunately\\ patients\\ starting\\ herparin\\ therapy\\ often\\ overshoot\\ their\\ goal\\ ptt\\ values\\ during\\ their\\ initial\\ titration\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ptt\\:\\ 0\\.08392957919064883\ \(0\)\
\-\ 133\\.7\\:\\ 0\\.08162517059228239\ \(0\)\
\-\ anticoagulation\\:\\ 0\\.07992053247474505\ \(0\)\
\-\ initiation\\:\\ 0\\.061280498579909984\ \(0\)\
\-\ goal\\:\\ 0\\.05145761005504644\ \(0\)\
\-\ starting\\:\\ 0\\.05044650549981503\ \(0\)\
\-\ drop\\:\\ 0\\.048705281134047075\ \(0\)\
\-\ heparin\\:\\ 0\\.048705281134047075\ \(0\)\
\-\ hemoglobin\\:\\ 0\\.048190745475206236\ \(0\)\
\-\ hematocrit\\:\\ 0\\.04658637768563182\ \(0\)\
\-\ 9\\.1\\/26\\.7\\:\\ 0\\.04081258529614119\ \(0\)\
\-\ 5\\.9\\/17\\.4\\:\\ 0\\.04081258529614119\ \(0\)\
\-\ adbominal\\:\\ 0\\.04081258529614119\ \(0\)\
\-\ 18\\.3\\:\\ 0\\.04081258529614119\ \(0\)\
\-\ 11\\-13\\.8\\:\\ 0\\.04081258529614119\ \(0\)\
\-\ 23\\.8\\-35\\.5\\:\\ 0\\.04081258529614119\ \(0\)\
\-\ anticoagultion\\:\\ 0\\.04081258529614119\ \(0\)\
\-\ herparin\\:\\ 0\\.04081258529614119\ \(0\)\
\-\ overshoot\\:\\ 0\\.037603570571326635\ \(0\)\
\-\ titration\\:\\ 0\\.037603570571326635\ \(0\)\
\-\ hemorrhage\\/hematoma\\:\\ 0\\.03572641729304809\ \(0\)\
\-\ her\\:\\ 0\\.035686273034512994\ \(0\)\
\-\ their\\:\\ 0\\.03463282045122844\ \(0\)\
\-\ 70\\-90\\:\\ 0\\.03439455584651207\ \(0\)\
\-\ 2\\.0\\.\\:\\ 0\\.033361483849687026\ \(0\)\
\-\ therapy\\:\\ 0\\.031731122170008515\ \(0\)\
\-\ withdrawal\\:\\ 0\\.031185541121697507\ \(0\)\
\-\ prior\\:\\ 0\\.0304737885028106\ \(0\)\
\-\ pt\\:\\ 0\\.029418182913266224\ \(0\)\
\-\ temporary\\:\\ 0\\.02769585685143649\ \(0\)\
\-\ intensive\\:\\ 0\\.02769585685143649\ \(0\)\
\-\ nml\\:\\ 0\\.027180923355555824\ \(0\)\
\-\ recent\\:\\ 0\\.026599250452220342\ \(0\)\
\-\ \\'s\\:\\ 0\\.026167314143986736\ \(0\)\
\-\ inr\\:\\ 0\\.024767511672068386\ \(0\)\
\-\ falls\\:\\ 0\\.024767511672068386\ \(0\)\
\-\ unit\\:\\ 0\\.02397190863074126\ \(0\)\
\-\ embolus\\:\\ 0\\.023851651749244685\ \(0\)\
\-\ abdomen\\:\\ 0\\.023438743174960152\ \(0\)\
\-\ pulmonary\\:\\ 0\\.023116206576111697\ \(0\)\
\-\ beyond\\:\\ 0\\.02298782788081685\ \(0\)\
\-\ wall\\:\\ 0\\.02291814000221061\ \(0\)\
\-\ receiving\\:\\ 0\\.022890358393789847\ \(0\)\
\-\ unfortunately\\:\\ 0\\.022701367678418294\ \(0\)\
\-\ following\\:\\ 0\\.022456275526862482\ \(0\)\
\-\ therapeutic\\:\\ 0\\.022260116845990864\ \(0\)\
\-\ ratio\\:\\ 0\\.02193509712991101\ \(0\)\
\-\ hour\\:\\ 0\\.021631406007291507\ \(0\)\
\-\ institution\\:\\ 0\\.021558496947253824\ \(0\)\
\-\ 56\\:\\ 0\\.02082421440013976\ \(0\)\
\-\ patient\\:\\ 0\\.01982851691936083\ \(0\)\
\-\ 1\\.5\\:\\ 0\\.019778813156002287\ \(0\)\
\-\ hyperdense\\:\\ 0\\.019778813156002287\ \(0\)\
\-\ values\\:\\ 0\\.019778813156002287\ \(0\)\
\-\ abdominal\\:\\ 0\\.019777029982612177\ \(0\)\
\-\ intravenous\\:\\ 0\\.019633367803069977\ \(0\)\
\-\ embolism\\:\\ 0\\.019355506646929917\ \(0\)\
\-\ period\\:\\ 0\\.018496466936858615\ \(0\)\
\-\ was\\:\\ 0\\.018301435596549755\ \(0\)\
\-\ sudden\\:\\ 0\\.018277703581069053\ \(0\)\
\-\ started\\:\\ 0\\.017646167213060365\ \(0\)\
\-\ development\\:\\ 0\\.017230408440554332\ \(0\)\
\-\ ct\\:\\ 0\\.01660143963044504\ \(0\)\
\-\ a\\:\\ 0\\.01652499174244172\ \(0\)\
\-\ just\\:\\ 0\\.01652080718428709\ \(0\)\
\-\ non\\:\\ 0\\.016353308774206064\ \(0\)\
\-\ tender\\:\\ 0\\.016057457839115875\ \(0\)\
\-\ 24\\:\\ 0\\.015381745280675692\ \(0\)\
\-\ sided\\:\\ 0\\.014627438023827061\ \(0\)\
\-\ laboratory\\:\\ 0\\.014579128406731786\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.014547199799976877\ \(0\)\
\-\ pelvis\\:\\ 0\\.014375423178664947\ \(0\)\
\-\ care\\:\\ 0\\.014269338643836817\ \(0\)\
\-\ hematoma\\:\\ 0\\.01407855036306523\ \(0\)\
\-\ palpable\\:\\ 0\\.014021393715739771\ \(0\)\
\-\ being\\:\\ 0\\.013786055448150732\ \(0\)\
\-\ neoplasm\\:\\ 0\\.01347294711070337\ \(0\)\
\-\ week\\:\\ 0\\.013435256566334389\ \(0\)\
\-\ elevated\\:\\ 0\\.013422760932217883\ \(0\)\
\-\ less\\:\\ 0\\.013397870390382788\ \(0\)\
\-\ initial\\:\\ 0\\.013109176589256056\ \(0\)\
\-\ often\\:\\ 0\\.01262256272462802\ \(0\)\
\-\ abscess\\:\\ 0\\.012508501130251237\ \(0\)\
\-\ found\\:\\ 0\\.012467711178019038\ \(0\)\
\-\ while\\:\\ 0\\.012447450184501451\ \(0\)\
\-\ during\\:\\ 0\\.012106524305202815\ \(0\)\
\-\ from\\:\\ 0\\.011726256603279743\ \(0\)\
\-\ scan\\:\\ 0\\.011075330835337863\ \(0\)\
\-\ mass\\:\\ 0\\.01100426858284782\ \(0\)\
\-\ at\\:\\ 0\\.01072002919288549\ \(0\)\
\-\ than\\:\\ 0\\.010365966920917935\ \(0\)\
\-\ patients\\:\\ 0\\.01023877129336123\ \(0\)\
\-\ for\\:\\ 0\\.010126502064482153\ \(0\)\
\-\ \\(\\:\\ 0\\.010032801753386951\ \(0\)\
\-\ \\)\\:\\ 0\\.009910245723795903\ \(0\)\
\-\ acute\\:\\ 0\\.009767959856974514\ \(0\)\
\-\ soft\\:\\ 0\\.009633920203673842\ \(0\)\
\-\ tissue\\:\\ 0\\.009376949946539785\ \(0\)\
\-\ present\\:\\ 0\\.00893522571264667\ \(0\)\
\-\ this\\:\\ 0\\.008899418641797528\ \(0\)\
\-\ contrast\\:\\ 0\\.008855442994481042\ \(0\)\
\-\ left\\:\\ 0\\.008852826567341803\ \(0\)\
\-\ \\,\\:\\ 0\\.008773011382504683\ \(0\)\
\-\ large\\:\\ 0\\.008650659406625369\ \(0\)\
\-\ demonstrates\\:\\ 0\\.008641764822468454\ \(0\)\
\-\ have\\:\\ 0\\.008566842955393943\ \(0\)\
\-\ lateral\\:\\ 0\\.008549389100113658\ \(0\)\
\-\ female\\:\\ 0\\.00813314940485108\ \(0\)\
\-\ within\\:\\ 0\\.007546904668454081\ \(0\)\
\-\ which\\:\\ 0\\.007384928644641429\ \(0\)\
\-\ the\\:\\ 0\\.007040472832129091\ \(0\)\
\-\ on\\:\\ 0\\.006702694558939149\ \(0\)\
\-\ by\\:\\ 0\\.006587365292800346\ \(0\)\
\-\ to\\:\\ 0\\.0059315015061525865\ \(0\)\
\-\ in\\:\\ 0\\.00585273930750354\ \(0\)\
\-\ not\\:\\ 0\\.0057167531099163674\ \(0\)\
\-\ year\\:\\ 0\\.004426413283670902\ \(0\)\
\-\ old\\:\\ 0\\.004050623133621549\ \(0\)\
\-\ of\\:\\ 0\\.003775586136971847\ \(0\)\
\-\ and\\:\\ 0\\.0033335001061521935\ \(0\)\
\-\ \\.\\:\\ 0\\.0013147976332350472\ \(0\)\
\-\ with\\:\\ 0\\.0005416860004161561\ \(0\)\
